{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T23:36:10Z","timestamp":1783294570979,"version":"3.54.6"},"reference-count":120,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Emergency Medicine Clinics of North America"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.emc.2022.01.008","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:35:11Z","timestamp":1649118911000},"page":"381-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Roles of Antidotes in Emergency Situations"],"prefix":"10.1016","volume":"40","author":[{"given":"Sasha K.","family":"Kaiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Dart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib1","first-page":"267","article-title":"Effect of inadequate antivenin stores on the medical treatment of crotalid envenomation","volume":"33","author":"Dart","year":"1991","journal-title":"Vet Hum Toxicol"},{"issue":"18","key":"10.1016\/j.emc.2022.01.008_bib2","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1001\/jama.1996.03540180064034","article-title":"Insufficient stocking of poisoning antidotes in hospital pharmacies","volume":"276","author":"Dart","year":"1996","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/ejhpharm-2015-000802","article-title":"Taking stock: UK national antidote availability increasing, but further improvements are required","volume":"23","author":"Bailey","year":"2016","journal-title":"Eur J Hosp Pharm"},{"issue":"2","key":"10.1016\/j.emc.2022.01.008_bib4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/bcpt.12897","article-title":"Antidote availability in Saudi Arabia hospitals in the Riyadh province","volume":"122","author":"AlTamimi","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.annemergmed.2017.05.021","article-title":"Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care","volume":"71","author":"Dart","year":"2018","journal-title":"Ann Emerg Med"},{"issue":"10","key":"10.1016\/j.emc.2022.01.008_bib6","doi-asserted-by":"crossref","first-page":"e46585","DOI":"10.1371\/journal.pone.0046585","article-title":"Methylene blue as a cerebral metabolic and hemodynamic enhancer","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.emc.2022.01.008_bib7","doi-asserted-by":"crossref","first-page":"16504","DOI":"10.1074\/jbc.M110.208447","article-title":"Alternative mitochondrial electron transfer as a novel strategy for neuroprotection","volume":"286","author":"Wen","year":"2011","journal-title":"J\u00a0Biol Chem"},{"issue":"7506","key":"10.1016\/j.emc.2022.01.008_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20140620","article-title":"Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria","volume":"462","author":"Bridges","year":"2014","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1074\/jbc.275.1.223","article-title":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I","volume":"275","author":"El-Mir","year":"2000","journal-title":"J\u00a0Biol Chem"},{"issue":"Pt 3","key":"10.1016\/j.emc.2022.01.008_bib11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem J"},{"issue":"11\u201312","key":"10.1016\/j.emc.2022.01.008_bib12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/0885066618793385","article-title":"Review of Biguanide (Metformin) Toxicity","volume":"34","author":"Wang","year":"2019","journal-title":"J\u00a0Intensive Care Med"},{"key":"10.1016\/j.emc.2022.01.008_bib13","doi-asserted-by":"crossref","first-page":"253a","DOI":"10.1378\/chest.1991940","article-title":"Successful use of methylene blue for hemodynamically unstable metformin toxicity","author":"Heredia","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.emc.2022.01.008_bib14","first-page":"611","article-title":"Severe metformin toxicity: role of methylene blue and CVVHD as therapeutic adjuncts","author":"Livshits","year":"2010","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.emc.2022.01.008_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-210229","article-title":"A\u00a0severe case of vasoplegic shock following metformin overdose successfully treated with methylene blue as a last line therapy","author":"Graham","year":"2015","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.emc.2022.01.008_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-008855","article-title":"Feeling blue with metformin-associated lactic acidosis","author":"Plumb","year":"2013","journal-title":"BMJ Case Rep."},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-5223(99)70161-3","article-title":"Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery","volume":"118","author":"Yiu","year":"1999","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.emc.2022.01.008_bib18","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1067\/mtc.2000.105833","article-title":"Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass","volume":"119","author":"Pagni","year":"2000","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.emc.2022.01.008_bib19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1067\/mtc.2001.115153","article-title":"Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation","volume":"122","author":"Kofidis","year":"2001","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.emc.2022.01.008_bib20","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0022-5223(02)73284-4","article-title":"Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?","volume":"125","author":"Leyh","year":"2003","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.emc.2022.01.008_bib21","first-page":"167","article-title":"Rescue therapy with methylene blue in systemic inflammatory response syndrome after cardiac surgery","volume":"19","author":"Dagenais","year":"2003","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1016\/j.emc.2022.01.008_bib22","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.athoracsur.2008.07.017","article-title":"Use of methylene blue for catecholamine-refractory vasoplegia from protamine and aprotinin","volume":"87","author":"Del Duca","year":"2009","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1213\/01.ane.0000221261.25310.fe","article-title":"The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass","volume":"103","author":"Maslow","year":"2006","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1051\/ject\/200840206","article-title":"Methylene blue-induced methemoglobinemia during cardiopulmonary bypass? A case report and literature review","volume":"40","author":"McRobb","year":"2008","journal-title":"J\u00a0Extra Corpor Technol"},{"issue":"6","key":"10.1016\/j.emc.2022.01.008_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0210-5691(06)74527-2","article-title":"[Use of methylene blue in the treatment of vasoplegic syndrome of post-operative heart surgery]","volume":"30","author":"Mora-Ord\u00f3\u00f1ez","year":"2006","journal-title":"Med Intensiva"},{"issue":"5","key":"10.1016\/j.emc.2022.01.008_bib26","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.athoracsur.2004.10.038","article-title":"Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery","volume":"79","author":"Ozal","year":"2005","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.emc.2022.01.008_bib27","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jtcvs.2005.01.001","article-title":"Methylene blue revisited: management of hypotension in a pediatric patient with bacterial endocarditis","volume":"130","author":"Taylor","year":"2005","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.emc.2022.01.008_bib28","first-page":"271","article-title":"Methylene blue for refractory hypotension: a case report","volume":"76","author":"Weissgerber","year":"2008","journal-title":"AANA J"},{"issue":"4","key":"10.1016\/j.emc.2022.01.008_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12630-011-9458-x","article-title":"Prolonged methylene blue infusion in refractory septic shock: a case report","volume":"58","author":"Dumbarton","year":"2011","journal-title":"Can J Anaesth"},{"issue":"4","key":"10.1016\/j.emc.2022.01.008_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.niox.2010.01.006","article-title":"A\u00a0dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock","volume":"22","author":"Juffermans","year":"2010","journal-title":"Nitric Oxide"},{"issue":"10","key":"10.1016\/j.emc.2022.01.008_bib31","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","article-title":"Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study","volume":"29","author":"Kirov","year":"2001","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.emc.2022.01.008_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00003246-199502000-00010","article-title":"Methylene blue administration in septic shock: a clinical trial","volume":"23","author":"Preiser","year":"1995","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.emc.2022.01.008_bib33","first-page":"CS102","article-title":"Methylene blue: an effective treatment for contrast medium-induced anaphylaxis","volume":"9","author":"Oliveira Neto","year":"2003","journal-title":"Med Sci Monit"},{"issue":"12","key":"10.1016\/j.emc.2022.01.008_bib34","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1586\/erc.11.160","article-title":"Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery","volume":"9","author":"Lenglet","year":"2011","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"4","key":"10.1016\/j.emc.2022.01.008_bib35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4103\/0970-9185.74599","article-title":"Methylene blue: revisited","volume":"26","author":"Ginimuge","year":"2010","journal-title":"J\u00a0Anaesthesiol Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.emc.2022.01.008_bib36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/15563650.2016.1180390","article-title":"A\u00a0systematic analysis of methylene blue for drug-induced shock","volume":"54","author":"Warrick","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"issue":"4","key":"10.1016\/j.emc.2022.01.008_bib37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00045391-200307000-00009","article-title":"Methylene blue","volume":"10","author":"Clifton","year":"2003","journal-title":"Am J Ther"},{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0033-3182(10)70685-X","article-title":"The role of methylene blue in serotonin syndrome: a systematic review","volume":"51","author":"Ng","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1016\/j.emc.2022.01.008_bib39","unstructured":"Howland M. Methylene Blue. In: Nelson LS, Howland M, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS. eds. Goldfrank's Toxicologic Emergencies, 11e. McGraw Hill; 2019. 1713\u20131716."},{"key":"10.1016\/j.emc.2022.01.008_bib40","unstructured":"Methylene Blue. Micromedex Solutions. Greenwood Village, CO: Truven Health Analytics. http:\/\/micromedex.com\/. Accessed February 18, 2022."},{"issue":"9","key":"10.1016\/j.emc.2022.01.008_bib41","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3109\/15563650.2011.617308","article-title":"Partition constant and volume of distribution as predictors of clinical efficacy of lipid rescue for toxicological emergencies","volume":"49","author":"French","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"issue":"9","key":"10.1016\/j.emc.2022.01.008_bib42","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/ndt\/14.9.2245","article-title":"Fever, shivering...and blue urine","volume":"14","author":"Prischl","year":"1999","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib43","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1345\/aph.1Q560","article-title":"Local cutaneous necrosis secondary to a prolonged peripheral infusion of methylene blue in vasodilatory shock","volume":"46","author":"Dumbarton","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.emc.2022.01.008_bib44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7800-2-26","article-title":"Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer","volume":"2","author":"Salhab","year":"2005","journal-title":"Int Semin Surg Oncol"},{"key":"10.1016\/j.emc.2022.01.008_bib45","unstructured":"Hydroxocobalamin. Micromedex Solutions. Greenwood Village, CO: Truven Health Analytics. http:\/\/micromedex.com\/. Accessed February 18, 2022."},{"issue":"4","key":"10.1016\/j.emc.2022.01.008_bib46","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.jvca.2018.08.017","article-title":"Hydroxocobalamin for the treatment of vasoplegia: a review of current literature and considerations for use","volume":"33","author":"Shapeton","year":"2019","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"Suppl 1","key":"10.1016\/j.emc.2022.01.008_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/15563650600811870","article-title":"Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade","volume":"44","author":"Fortin","year":"2006","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.emc.2022.01.008_bib48","unstructured":"Howland M. Hydroxocobalamin. In: Nelson LS, Howland M, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS. eds. Goldfrank's Toxicologic Emergencies, 11e. McGraw Hill; 2019. 1694\u20131697."},{"issue":"4","key":"10.1016\/j.emc.2022.01.008_bib49","first-page":"e0408","article-title":"Hydroxocobalamin in refractory septic shock: a retrospective case series","volume":"3","author":"Sacco","year":"2021","journal-title":"Crit Care Explor"},{"issue":"6","key":"10.1016\/j.emc.2022.01.008_bib50","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/15563650701829763","article-title":"Changes in blood pressure after administration of hydroxocobalamin: relationship to changes in plasma cobalamins-(III) concentrations in healthy volunteers","volume":"46","author":"Uhl","year":"2008","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0022-3565(25)09522-9","article-title":"Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypotension and mortality in rodents: role of nitric oxide","volume":"273","author":"Greenberg","year":"1995","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.emc.2022.01.008_bib52","doi-asserted-by":"crossref","first-page":"741804","DOI":"10.1155\/2013\/741804","article-title":"Biphasic modulation of NOS expression, protein and nitrite products by hydroxocobalamin underlies its protective effect in endotoxemic shock: downstream regulation of COX-2, IL-1\u03b2, TNF-\u03b1, IL-6, and HMGB1 expression","volume":"2013","author":"Sampaio","year":"2013","journal-title":"Mediators Inflamm"},{"issue":"5","key":"10.1016\/j.emc.2022.01.008_bib53","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.athoracsur.2013.08.050","article-title":"The use of high-dose hydroxocobalamin for vasoplegic syndrome","volume":"97","author":"Roderique","year":"2014","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.emc.2022.01.008_bib54","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4103\/aca.ACA_88_17","article-title":"The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery","volume":"20","author":"Cai","year":"2017","journal-title":"Ann Card Anaesth"},{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib55","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.jvca.2016.08.019","article-title":"Hydroxocobalamin as a rescue treatment for refractory vasoplegic syndrome after prolonged cardiopulmonary bypass","volume":"31","author":"Burnes","year":"2017","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"12","key":"10.1016\/j.emc.2022.01.008_bib56","first-page":"247","article-title":"Hydroxocobalamin for vasoplegic syndrome in liver transplantation: restoration of blood pressure without vasospasm","volume":"7","author":"Woehlck","year":"2016","journal-title":"A\u00a0A Case Rep"},{"issue":"6","key":"10.1016\/j.emc.2022.01.008_bib57","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/ajt.14736","article-title":"Case report of high-dose hydroxocobalamin in the treatment of vasoplegic syndrome during liver transplantation","volume":"18","author":"An","year":"2018","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.emc.2022.01.008_bib58","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s12630-017-0849-5","article-title":"Red urinary discolouration following hydroxocobalamin treatment for vasoplegic syndrome","volume":"64","author":"Warner","year":"2017","journal-title":"Can J Anaesth"},{"issue":"5","key":"10.1016\/j.emc.2022.01.008_bib59","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12630-017-1029-3","article-title":"Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case series","volume":"65","author":"Shah","year":"2018","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.emc.2022.01.008_bib60","unstructured":"Cyanokit Package Insert. In: Meridian Medical Technologies. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2006\/022041lbl.pdf. Accessed February 18, 2022."},{"issue":"4","key":"10.1016\/j.emc.2022.01.008_bib61","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/j.jvca.2016.10.011","article-title":"Treatment of vasoplegic syndrome with intravenous hydroxocobalamin during liver transplantation","volume":"31","author":"Boettcher","year":"2017","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"2","key":"10.1016\/j.emc.2022.01.008_bib62","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.mjt.0000174349.89671.8c","article-title":"Hydroxocobalamin as a cyanide antidote","volume":"13","author":"DesLauriers","year":"2006","journal-title":"Am J Ther"},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ekir.2018.10.010","article-title":"Hydroxocobalamin as a cause of oxalate nephropathy","volume":"4","author":"Legrand","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib64","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s13054-019-2706-0","article-title":"Association between hydroxocobalamin administration and acute kidney injury after smoke inhalation: a multicenter retrospective study","volume":"23","author":"D\u00e9pret","year":"2019","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.emc.2022.01.008_bib65","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1007\/s00134-016-4252-4","article-title":"Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients","volume":"42","author":"Legrand","year":"2016","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib66","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/ckj\/sfx004","article-title":"High-dose hydroxocobalamin for vasoplegic syndrome causing false blood leak alarm","volume":"10","author":"Cheungpasitporn","year":"2017","journal-title":"Clin Kidney J"},{"issue":"24","key":"10.1016\/j.emc.2022.01.008_bib67","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198812153192401","article-title":"Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)","volume":"319","author":"Smilkstein","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.emc.2022.01.008_bib68","unstructured":"Acetylcysteine. Micromedex Solutions. Greenwood Village, CO: Truven Health Analytics. http:\/\/micromedex.com\/. Accessed February 18, 2022."},{"key":"10.1016\/j.emc.2022.01.008_bib69","unstructured":"Acetadote (acetylcysteine) Injection Package Insert. In: Cumberland Pharmaceuticals. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2006\/021539s004lbl.pdf. Accessed February 18, 2022."},{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib70","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/15563650.2018.1510127","article-title":"Transition to two-bag intravenous acetylcysteine for acetaminophen overdose: a poison center's experience","volume":"57","author":"Hoyte","year":"2019","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"10.1016\/j.emc.2022.01.008_bib71","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/15563650.2012.659252","article-title":"Acetaminophen and acetylcysteine dose and duration: past, present and future","volume":"50","author":"Rumack","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib72","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1553-2712.2008.00296.x","article-title":"Hepatotoxicity despite early administration of intravenous N-acetylcysteine for acute acetaminophen overdose","volume":"16","author":"Doyon","year":"2009","journal-title":"Acad Emerg Med"},{"issue":"6","key":"10.1016\/j.emc.2022.01.008_bib73","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/bcp.13214","article-title":"Outcomes from massive paracetamol overdose: a retrospective observational study","volume":"83","author":"Marks","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.emc.2022.01.008_bib74","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/15563650.2017.1334915","article-title":"Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2)","volume":"55","author":"Chiew","year":"2017","journal-title":"Clin Toxicol (Phila)"},{"issue":"5","key":"10.1016\/j.emc.2022.01.008_bib75","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/15563650.2016.1159309","article-title":"Plasma paracetamol concentration at hospital presentation has a dose-dependent relationship with liver injury despite prompt treatment with intravenous acetylcysteine","volume":"54","author":"Cairney","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"10.1016\/j.emc.2022.01.008_bib76","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/15563650802665587","article-title":"Adverse reactions associated with acetylcysteine","volume":"47","author":"Sandilands","year":"2009","journal-title":"Clin Toxicol (Phila)"},{"issue":"11","key":"10.1016\/j.emc.2022.01.008_bib77","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1080\/15563650.2018.1475672","article-title":"Fewer adverse effects associated with a modified two-bag intravenous acetylcysteine protocol compared to traditional three-bag regimen in paracetamol overdose","volume":"56","author":"Schmidt","year":"2018","journal-title":"Clin Toxicol (Phila)"},{"issue":"11","key":"10.1016\/j.emc.2022.01.008_bib78","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM199903183401102","article-title":"Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group","volume":"340","author":"Brent","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.emc.2022.01.008_bib79","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1056\/NEJMct0806112","article-title":"Fomepizole for ethylene glycol and methanol poisoning","volume":"360","author":"Brent","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.emc.2022.01.008_bib80","series-title":"Casarret & Doull's toxicology: the basic science of poisons","first-page":"557","article-title":"Toxic responses of the liver","author":"Jaeschke","year":"2019"},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib81","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/MJT.0b013e3181ff7ac0","article-title":"A\u00a0gargantuan acetaminophen level in an acidemic patient treated solely with intravenous N-acetylcysteine","volume":"20","author":"Zell-Kanter","year":"2013","journal-title":"Am J Ther"},{"issue":"2","key":"10.1016\/j.emc.2022.01.008_bib82","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s13181-019-00740-z","article-title":"The effect of 4-methylpyrazole on oxidative metabolism of acetaminophen in human volunteers","volume":"16","author":"Kang","year":"2020","journal-title":"J\u00a0Med Toxicol"},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib83","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/toxsci\/kfz077","article-title":"Delayed treatment with 4-methylpyrazole protects against acetaminophen hepatotoxicity in mice by inhibition of c-Jun n-terminal kinase","volume":"170","author":"Akakpo","year":"2019","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.emc.2022.01.008_bib84","doi-asserted-by":"crossref","unstructured":"Rampon G, Wartman H, Osmon S, et\u00a0al. Use of fomepizole as an adjunct in the treatment of acetaminophen overdose: a case series. In: Toxicology communications 2020. p. 1-4.","DOI":"10.1080\/24734306.2019.1705596"},{"key":"10.1016\/j.emc.2022.01.008_bib85","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/01.ccm.0000633332.08553.32","article-title":"Use of fomepizole and hemodialysis for massive acetaminophen toxicity","author":"Colon Hidalgo","year":"2020","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.emc.2022.01.008_bib86","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ajem.2019.09.005","article-title":"Fomepizole as an adjunctive treatment in severe acetaminophen toxicity","volume":"38","author":"Shah","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib87","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/15563650.2020.1775847","article-title":"Fomepizole as an adjunctive treatment in severe acetaminophen ingestions: a case series","volume":"59","author":"Shah","year":"2021","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib88","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ajem.2019.09.026","article-title":"Use of fomepizole, n-acetylcysteine, and hemodialysis for massive acetaminophen overdose","volume":"38","author":"Woolum","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.emc.2022.01.008_bib89","first-page":"9301432","article-title":"A\u00a0case report of massive acetaminophen poisoning treated with a novel \"triple therapy\": n-acetylcysteine, 4-methylpyrazole, and hemodialysis","volume":"2019","author":"Kiernan","year":"2019","journal-title":"Case Rep Emerg Med"},{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib90","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s13181-015-0492-x","article-title":"Case files from the University of California San Diego health system fellowship coma and severe acidosis: remember to consider acetaminophen","volume":"11","author":"Villano","year":"2015","journal-title":"J\u00a0Med Toxicol"},{"issue":"5","key":"10.1016\/j.emc.2022.01.008_bib91","first-page":"e8179","article-title":"Methanol, paracetamol toxicities and acute blindness","volume":"12","author":"Althwanay","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.emc.2022.01.008_bib92","unstructured":"Antizol (fomepizole) Injection [package insert]. In. Paladin Labs Inc. St-Laurent, Quebec. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/020696s006lbl.pdf. Accessed February 18, 2022."},{"issue":"2","key":"10.1016\/j.emc.2022.01.008_bib93","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/0091270008327142","article-title":"Fomepizole: a critical assessment of current dosing recommendations","volume":"49","author":"Bestic","year":"2009","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.emc.2022.01.008_bib94","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s001340101011","article-title":"Treatment of acute methanol poisoning with fomepizole","volume":"27","author":"M\u00e9garbane","year":"2001","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.emc.2022.01.008_bib95","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM200102083440605","article-title":"Fomepizole for the treatment of methanol poisoning","volume":"344","author":"Brent","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.emc.2022.01.008_bib96","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1530-0277.1988.tb00235.x","article-title":"4-Methylpyrazole: a controlled study of safety in healthy human subjects after single, ascending doses","volume":"12","author":"Jacobsen","year":"1988","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib97","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/1389201033489829","article-title":"Carnitine metabolism and deficit--when supplementation is necessary?","volume":"4","author":"Evangeliou","year":"2003","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.emc.2022.01.008_bib98","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1743-7075-7-30","article-title":"Role of carnitine in disease","volume":"7","author":"Flanagan","year":"2010","journal-title":"Nutr Metab (Lond)"},{"issue":"5","key":"10.1016\/j.emc.2022.01.008_bib99","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/cc3742","article-title":"Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?","volume":"9","author":"Lheureux","year":"2005","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.emc.2022.01.008_bib100","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1212\/WNL.56.10.1405","article-title":"Effect of L-carnitine treatment for valproate-induced hepatotoxicity","volume":"56","author":"Bohan","year":"2001","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.emc.2022.01.008_bib101","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0022-3476(82)80320-X","article-title":"Carnitine deficiency and hyperammonemia associated with valproic acid therapy","volume":"101","author":"Ohtani","year":"1982","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.emc.2022.01.008_bib102","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1651-2227.1996.tb14058.x","article-title":"The effect of carnitine supplementation in valproate-induced hyperammonaemia","volume":"85","author":"B\u00f6hles","year":"1996","journal-title":"Acta Paediatr"},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib103","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jat\/20.1.55","article-title":"Valproic acid overdose and L-carnitine therapy","volume":"20","author":"Ishikura","year":"1996","journal-title":"J\u00a0Anal Toxicol"},{"issue":"7","key":"10.1016\/j.emc.2022.01.008_bib104","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1528-1157.1996.tb00634.x","article-title":"Effect of L-carnitine supplementation on acute valproate intoxication","volume":"37","author":"Murakami","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.emc.2022.01.008_bib105","unstructured":"Carnitor (levocarnitine) Injection [package insert]. In: Bedford Laboratories. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2006\/021539s004lbl.pdf. Accessed February 18, 2022."},{"key":"10.1016\/j.emc.2022.01.008_bib106","author":"Howland"},{"key":"10.1016\/j.emc.2022.01.008_bib107","unstructured":"Levocarnitine (Carnitine). In. Greenwood Village, CO: Truven Health Analytics. http:\/\/micromedex.com\/. Accessed February 18, 2022."},{"issue":"6","key":"10.1016\/j.emc.2022.01.008_bib108","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/PEC.0000000000000155","article-title":"Review of the use of lipid emulsion in nonlocal anesthetic poisoning","volume":"30","author":"Kostic","year":"2014","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.emc.2022.01.008_bib109","unstructured":"Intralipid. Micromedex Solutions. Greenwood Village, CO: Truven Health Analytics. http:\/\/micromedex.com\/. Accessed February 18, 2022."},{"issue":"18 Suppl 2","key":"10.1016\/j.emc.2022.01.008_bib110","first-page":"S501","article-title":"Part 10: special circumstances of resuscitation: 2015 American heart association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"132","author":"Lavonas","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib111","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/ALN.0b013e31825ad8de","article-title":"Lipid emulsion infusion: resuscitation for local anesthetic and other drug overdose","volume":"117","author":"Weinberg","year":"2012","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib112","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s13181-016-0550-z","article-title":"ACMT Position Statement: Guidance for the Use of Intravenous Lipid Emulsion [published correction appears in J Med Toxicol. 2016 Dec;12 (4):416]","volume":"13","author":"American College of Medical Toxicology","year":"2017","journal-title":"J Med Toxicol"},{"issue":"2","key":"10.1016\/j.emc.2022.01.008_bib113","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/ALN.0b013e3182054d22","article-title":"Lipid emulsion reverses Levobupivacaine-induced responses in isolated rat aortic vessels","volume":"114","author":"Ok","year":"2011","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib114","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/15563650.2015.1126286","article-title":"Systematic review of the effect of intravenous lipid emulsion therapy for non-local anesthetics toxicity","volume":"54","author":"Levine","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"issue":"4","key":"10.1016\/j.emc.2022.01.008_bib115","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/00000542-199804000-00028","article-title":"Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats","volume":"88","author":"Weinberg","year":"1998","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563650903544124","article-title":"Lipid emulsions in the treatment of acute poisoning: a systematic review of human and animal studies","volume":"48","author":"Jamaty","year":"2010","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib117","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/15563650.2015.1121270","article-title":"Systematic review of the effect of intravenous lipid emulsion therapy for local anesthetic toxicity","volume":"54","author":"Hoegberg","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"10.1016\/j.emc.2022.01.008_bib118","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/15563650903555294","article-title":"Intentional overdose with cardiac arrest treated with intravenous fat emulsion and high-dose insulin","volume":"48","author":"Stellpflug","year":"2010","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib119","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s13181-011-0187-x","article-title":"Clinical experience with intravenous lipid emulsion for drug-induced cardiovascular collapse","volume":"8","author":"Geib","year":"2012","journal-title":"J\u00a0Med Toxicol"},{"issue":"1","key":"10.1016\/j.emc.2022.01.008_bib120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s13181-013-0356-1","article-title":"Complications following antidotal use of intravenous lipid emulsion therapy","volume":"10","author":"Levine","year":"2014","journal-title":"J\u00a0Med Toxicol"}],"container-title":["Emergency Medicine Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862722000086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862722000086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:40:08Z","timestamp":1760006408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733862722000086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":120,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0733862722000086"],"URL":"https:\/\/doi.org\/10.1016\/j.emc.2022.01.008","relation":{},"ISSN":["0733-8627"],"issn-type":[{"value":"0733-8627","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Roles of Antidotes in Emergency Situations","name":"articletitle","label":"Article Title"},{"value":"Emergency Medicine Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.emc.2022.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}